NovaBay Pharmaceuticals Stock Forecast - Rate Of Daily Change

NBY Stock  USD 0.08  0  1.33%   
NovaBay Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast NovaBay Pharmaceuticals stock prices and determine the direction of NovaBay Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of NovaBay Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns. Although NovaBay Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of NovaBay Pharmaceuticals' systematic risk associated with finding meaningful patterns of NovaBay Pharmaceuticals fundamentals over time.
Check out Historical Fundamental Analysis of NovaBay Pharmaceuticals to cross-verify your projections.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.
  
At this time, NovaBay Pharmaceuticals' Receivables Turnover is fairly stable compared to the past year. Fixed Asset Turnover is likely to rise to 11.16 in 2024, whereas Inventory Turnover is likely to drop 2.29 in 2024. . Common Stock Shares Outstanding is likely to rise to about 4.4 M in 2024, whereas Net Loss is likely to drop (15.4 M) in 2024.
NovaBay Pharmaceuticals has current Rate Of Daily Change of 1.01.
Most investors in NovaBay Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the NovaBay Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets NovaBay Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
Rate Of Daily Change (RDOC) indicator calculates rate of change of a given period over the current closing price of NovaBay Pharmaceuticals.
Check NovaBay Pharmaceuticals VolatilityBacktest NovaBay PharmaceuticalsInformation Ratio  

NovaBay Pharmaceuticals Trading Date Momentum

On April 18 2024 NovaBay Pharmaceuticals was traded for  0.08  at the closing time. Highest NovaBay Pharmaceuticals's price during the trading hours was 0.09  and the lowest price during the day was  0.08 . The net volume was 3.5 M. The overall trading history on the 18th of April 2024 did not cause price change. The trading delta at closing time to current price is 4.76% .
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period.
Compare NovaBay Pharmaceuticals to competition

Other Forecasting Options for NovaBay Pharmaceuticals

For every potential investor in NovaBay, whether a beginner or expert, NovaBay Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. NovaBay Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in NovaBay. Basic forecasting techniques help filter out the noise by identifying NovaBay Pharmaceuticals' price trends.

NovaBay Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NovaBay Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of NovaBay Pharmaceuticals could also be used in its relative valuation, which is a method of valuing NovaBay Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

NovaBay Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of NovaBay Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of NovaBay Pharmaceuticals' current price.

NovaBay Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how NovaBay Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NovaBay Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying NovaBay Pharmaceuticals stock market strength indicators, traders can identify NovaBay Pharmaceuticals entry and exit signals to maximize returns.

NovaBay Pharmaceuticals Risk Indicators

The analysis of NovaBay Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in NovaBay Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting novabay stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether NovaBay Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NovaBay Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novabay Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novabay Pharmaceuticals Stock:
Check out Historical Fundamental Analysis of NovaBay Pharmaceuticals to cross-verify your projections.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.
Note that the NovaBay Pharmaceuticals information on this page should be used as a complementary analysis to other NovaBay Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for NovaBay Stock analysis

When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Is NovaBay Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NovaBay Pharmaceuticals. If investors know NovaBay will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NovaBay Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.96)
Revenue Per Share
3.494
Quarterly Revenue Growth
0.023
Return On Assets
(0.25)
Return On Equity
(1.39)
The market value of NovaBay Pharmaceuticals is measured differently than its book value, which is the value of NovaBay that is recorded on the company's balance sheet. Investors also form their own opinion of NovaBay Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is NovaBay Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NovaBay Pharmaceuticals' market value can be influenced by many factors that don't directly affect NovaBay Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NovaBay Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if NovaBay Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NovaBay Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.